Skip to content
Open access

Signatures of nonsense-mediated mRNA decay but no evidence for transcriptional adaptation associated with protein-truncating variants in wild yeast diploids

Aug 2026 · Molecular biology and evolution · Vol 43 · 0 citations · 67 references
Medicine

TL;DR

Overall, the findings suggest that TA is not a universal response to loss-of-function mutations in yeast, and the ability to resist specific transcriptomic ruptures would thus rely mostly on the general robustness of genetic networks.

Abstract

Abstract Transcriptional adaptation (TA) is a regulatory process in which loss or disruption of gene function caused by protein-truncating variants (PTVs) triggers compensatory changes in expression of the healthy allele or in expression of related genes. Nonsense-mediated mRNA decay (NMD), a conserved RNA surveillance pathway that degrades transcripts containing premature termination codons, is required to initiate this process. In natural yeast populations, PTV mutations occur relatively frequently, raising the question of whether and how their effects are mitigated. In this study, we investigated TA and NMD among PTVs occurring in natural yeast populations. We observed a strong reduction in the abundance of PTV-containing transcripts, suggesting efficient recognition and degradation of transcripts containing premature stop codons. However, despite evidence of this mRNA surveillance activity, we did not detect a clear signature of transcriptional adaptation. While compensation may still occur in specific contexts, particularly for dosage-sensitive genes, it does not appear to represent a general response to PTVs in yeast. The transcriptional deregulation caused by PTVs in natural isolates may be causing too little harm to favor the evolution or maintenance of complex mechanisms required for adequate compensation. The ability to resist specific transcriptomic ruptures would thus rely mostly on the general robustness of genetic networks. Overall, our findings suggest that TA is not a universal response to loss-of-function mutations in yeast.

Read PDF

Similar papers

Review Jul 2026

Nonsense-mediated mRNA decay as a gatekeeper of neoantigen expression: Bridging RNA surveillance and tumor immunotherapy

Targeting NMD has the potential to open new avenues for precision cancer therapy by revealing the previously unrealized immunogenic potential of tumors and bridging the gap between RNA biology and cancer immunotherapy.

Sanjoy Majumder, G. K. Panigrahi, Annapurna Sahoo · 0 citations
Review Open access Jul 2026

DIS3L2 and nonsense-mediated decay: united to degrade.

Nonsense-mediated decay (NMD) is a vital RNA surveillance mechanism in eukaryotic cells that ensures mRNA quality and regulates gene expression. NMD targets mRNAs with premature translation-termination codons to prevent the production of potentially harmful truncated proteins. But NMD is also involved in modulating the...

Rafaela Lacerda, Miguel Carvalho, L. Romão · 1 citation
Open access Aug 2026

Position-Dependent NMD Generates Diverse Protein Outcomes

It is shown that PTC location critically determines not only NMD efficiency and its variability across cells, but also the spectrum of resulting protein products, including truncated proteins arising from premature termination, full-length proteins generated through translational readthrough, and N-terminally truncated...

Nusrat Jahan Pinky, Hanae Sato · 0 citations
#protein folding Open access Aug 2026

16S ribosomal RNA modification drives transcript-specific translation efficiency

It is proposed that MraW modification of 16S rRNA enhances translation efficiency in general, and that specific transcripts have evolved structural features that fine-tune protein levels that may be prevalent in bacteria which exhibit uncoupled transcription and translation.

Zachory M. Park, Christina R. Savage, Amanda R. Decker-Farrell et al. · 0 citations
#gene editing Open access Jul 2026

CRISPR-mediated Correction of Oncogenic AS-NMD in Splicing Factor Mutant Cancer

The CRISPR strategy shows compelling evidence as a therapeutic approach targeting PE in cancer and other human diseases as well as the preferential advantages of CRISPR over the antisense technology recently developed targeting the PE of EZH2.

Preeti Nagar, Md Rafikul Islam, Nirjhor Anuvob Rahman et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.